Anokion is Drug Discovery in Switzerland that focus on diabetes which business. Founded in 2010. They cover business area such as developer, antigen-specific immunotherapy, service, antigen-specific immune tolerance, both prevalent and rare autoimmune disease, celiac disease, multiple sclerosis, protein, precise therapy, doctor, outcome.
2010
( 14 years old in 2024 )
Diabetes Which
-
EPFL Innovation Park-L
Chemin de la Dent d'Oche 1A
1024 Ecublens
Switzerland
Private
developerantigen-specific immunotherapyserviceantigen-specific immune toleranceboth prevalent and rare autoimmune diseaseceliac diseasemultiple sclerosisproteinprecise therapydoctoroutcome
* We use standard office opening hours in near Anokion's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anokion is Drug Discovery business from Switzerland that founded in 2010 (14 years old in 2024), Anokion business is focusing on Diabetes Which.
Anokion headquarter office and corporate office address is located in EPFL Innovation Park-L Chemin de la Dent d'Oche 1A 1024 Ecublens Switzerland.
Anokion was founded in Switzerland.
In 2024, Anokion is currently focus on diabetes which sector.
Above is snippet of Google Trends for "diabetes which" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anokion, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
